Endoscopic approach to gastrointestinal stromal tumors.

Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.

The skeptical endoscopist.

Development of an instrument to assess and predict satisfaction and poor tolerance among patients undergoing endoscopic procedures.

Development of an instrument to assess and predict satisfaction and poor tolerance among patients undergoing endoscopic procedures.

[Anonymous].  2005.  Development of an instrument to assess and predict satisfaction and poor tolerance among patients undergoing endoscopic procedures.. Digestive diseases and sciences. 50(10):1860-71.

Retrograde esophageal dilation using Savary dilators.

An instrument to predict endoscopy tolerance: a prospective randomized study.

EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurement.

Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.

Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.

[Anonymous].  2009.  Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.. Gastrointestinal endoscopy. 69(3 Pt 1):462-72.

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.

Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease.

Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease.

[Anonymous].  2010.  Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease.. Surgical endoscopy. 24(6):1387-97.